The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Gut microbiome diversity as an independent predictor of survival in cervical cancer patients receiving chemoradiation.
 
Travis T. Sims
No Relationships to Disclose
 
Molly B. Alam
No Relationships to Disclose
 
Tatiana Karpinets
No Relationships to Disclose
 
Kyoko Yoshida-Court
No Relationships to Disclose
 
Greyson W.G. Biegert
No Relationships to Disclose
 
Mustapha Ahmed-Kaddar
No Relationships to Disclose
 
Xiaogang Wu
No Relationships to Disclose
 
Andrea Delgado Medrano
No Relationships to Disclose
 
Bhavana Sree Vangara Chapman
No Relationships to Disclose
 
Travis Solley
No Relationships to Disclose
 
Mitra Aparna
No Relationships to Disclose
 
Melissa P. Mezzari
No Relationships to Disclose
 
Lois M. Ramondetta
No Relationships to Disclose
 
Lilie L. Lin
No Relationships to Disclose
 
Anuja Jhingran
No Relationships to Disclose
 
Kathleen M. Schmeler
Patents, Royalties, Other Intellectual Property - UpToDate
 
Nadim J Ajami
No Relationships to Disclose
 
Jennifer Ann Wargo
Leadership - Microbiome DX
Honoraria - AstraZeneca/MedImmune; Bristol-Myers Squibb; Dava Oncology; Genentech; Gilead Sciences; GlaxoSmithKline; Illumina; Merck; Novartis; Society for Immunotherapy of Cancer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genentech; GlaxoSmithKline; Illumina; Merck; Novartis
Speakers' Bureau - Dava Oncology; Genentech; Illumina; Novartis; PER; Precision Health Economics; Precision Health Economics
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Patent submitted regarding the role of the microbiome in response to immune checkpoint blockade
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Dava Oncology; Genentech; GlaxoSmithKline; Illumina; Novartis
 
Lauren Elizabeth Colbert
No Relationships to Disclose
 
Ann Klopp
No Relationships to Disclose